Interview: Sun looks to "quality by design" to overcome business challenges
This article was originally published in Scrip
Executive Summary
The approach road to Sun Pharmaceutical Industries' office in an industrial hub of suburban Mumbai is bumpy with pits and rough stone edges, somewhat reminiscent of the challenges that the Indian company has faced over the recent past with the US FDA and its planned takeover of the Israeli firm Taro.